ESG Performance & Reporting

Striving for Continuous Improvement

Our sustainability performance is regularly assessed by ESG rating agencies. We are happy to receive valuable feedback from outside, which we can use to grow further. Here, we essentially focus on five key ratings and strive for continuous improvement for our company. In addition to the listed ratings, we aim to participate in the CDP Climate rating process from 2023. In the following, we create transparency about the current overall rating results.

ESG Ratings Overview

EcoVadis

Ecovardis Bronze Sustainability Rating 2021

The EcoVadis methodology framework assesses companies' policies and actions as well as their published reporting related to the environment, labor and human rights, ethics and sustainable procurement. Their team of international sustainability experts analyse and crosscheck companies’ data (supporting documents, 360° Watch Findings, etc.) in order to create reliable ratings, taking into account each company’s industry, size and geographic location. To find out more, visit ecovadis.com.

ISS ESG

ISS ESG Logo

If you want to find out more about the ISS ESG Corporate Rating, please follow the corresponding link here.

MSCI ESG Rating

MSCI ESG Ratings AA

In 2023, Evotec received a rating of AA (on a scale of AAA-CCC) in the MSCI ESG Ratings assessment.


Disclaimer: The use by Evotec of any MSCI ESG RESEARCH LLC or its affiliates (“MSCI”) data, and the use of MSCI logos, trademarks, service marks or index names herein, do not constitute a sponsorship, endorsement, recommendation, or promotion of Evotec by MSCI.  MSCI services and data are the property of MSCI or its information providers, and are provided ‘as-is’ and without warranty.  MSCI names and logos are trademarks or service marks of MSCI.  


For more information on MSCI, click here.

Sustainalytics

Sustainalytics Rated

Sustainalytics’ ESG Risk Ratings measure a company’s exposure to industry-specific material ESG risks and how well a company is managing those risks. This multi-dimensional way of measuring ESG risk combines the concepts of management and exposure to arrive at an assessment of ESG risk, i.e. a total unmanaged ESG risk score or the ESG Risk Rating, that is comparable across all industries. Sustainalytics’ ESG Risk Ratings provide a quantitative measure of unmanaged ESG risk and distinguish between five levels of risk: negligible, low, medium, high and severe. Learn more about the ESG Risk Ratings here.

Vigeo Eiris

Vigeo Eiris

V.E, part of Moody’s ESG Solutions. For more information visit www.vigeo-eiris.com

CDP Climate Change Score

CDP Logo


The Carbon Disclosure Project, CDP for short, is an international non-profit organisation that supports companies and cities in disclosing their environmental impact by providing a platform. CDP is disclosure platform for companies on climate change, forests, water security and supply chains that improves corporate awareness through measurement and disclosure is essential to the effective management of carbon and climate change risk. It validates information on climate risks and low carbon opportunities from the world’s largest companies that are disclosed at the request of their stakeholders or voluntarily. Click here to learn more.


Sustainability Reporting

Since 2017, Evotec is reporting on non-financial topics in line with the German Commercial Code. For the financial year 2020 we started to extend the scope of this report to voluntary sustainability disclosures. In 2021 and 2022, we reported in reference to the Global Reporting Initiative (GRI) standards in an effort to continue improving our Sustainability Report. In 2022, a selection of our material topics in the Sustainability Report were audited to increase transparency and trust among our external stakeholders. We aim to perform a new materiality analysis applying the double materiality approach and report based on the results for fiscal year 2023.

Downloads

You might be interested in...

ESG white 309

Evotec ESG Team

vCard
Logo Evotec white
Evotec has the right technologies & disease understanding to meet our partners' evolving needs: a comprehensive disease knowledge at the molecular level, cutting-edge technologies & platforms to translate this expertise into effective precision medicines.